PORTLAND, Ore., March 23, 2021 /PRNewswire/ -- Allied Market Research published a report, titled, "Inhaled Nitric Oxide Market by Application (Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027" According to the report, the global inhaled nitric oxide industry generated $634.4 million in 2019, is projected to reach $1.18 billion in 2027, witnessing a CAGR of 8.1% from 2020 to 2027.
Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/3020
Drivers, restraints, and opportunities
Growing demand from the healthcare sector and rise in chronic diseases drive the growth of the global inhaled nitric oxide market. However, high cost of treatment and stringent application norms hinder the market growth. On the other hand, ongoing R&D activities that are leading to new application areas in the healthcare industry create new opportunities in the coming years.
Covid-19 Scenario
- Owing to the antiviral property and improved oxygenation found in the inhaled nitric oxide, nitric oxide is being tested as an experimental treatment for COVID-19. In addition, several undergoing randomized clinical trials have been conducted to investigate the role of inhaled nitric oxide in COVID-19.
- It has also been helpful in protecting healthcare workers on the front line of the pandemic from getting sick.
The neonatal respiratory treatment segment to maintain its dominance in terms of revenue during the forecast period
Based on application, the neonatal respiratory treatment segment contributed to the highest share in terms of revenue in 2019, accounting for more than four-fifths of the global inhaled nitric oxide market, and is projected to maintain its dominance in terms of revenue during the forecast period. In addition, this segment is projected to portray the highest CAGR of 8.4% from 2020 to 2027. This is attributed to the increase in the prevalence of diseases in the newborn such as persistent pulmonary hypertension, and neonatal hypoxic respiratory failure (HRF).
Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/3020
North America to maintain its leadership status by 2027
Based on region, North America held the largest market share in 2019, contributing to more than four-fifths of the global inhaled nitric oxide market, and will maintain its leadership status by 2027. Furthermore, the region grow at the highest CAGR of 8.3% during the forecast period. This is attributed to a large consumer base and increasing investment in R&D by the market players in the region.
Leading market players
- Air Liquide S.A
- Bellerophon Therapeutics, Inc.
- BOC Healthcare
- Beyond Air, Inc
- Halma Plc
- Linde Plc
- Mallinckrodt plc
- Novoteris, LLC
- VERO Biotech LLC
- Nu-Med Plus.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.
Similar Reports:
Respiratory Care Devices Market - Global Opportunity Analysis and Industry Forecast, 2020–2027
Asthma and COPD Drugs Market - Global Opportunity Analysis and Industry Forecast, 2019-2027
Mechanical Ventilators Market - Global Opportunity Analysis and Industry Forecast, 2019–2027
Digital Therapeutics Market - Global Opportunity Analysis and Industry Forecast, 2019–2027
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022, 1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
SOURCE Allied Market Research
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article